Once daily long‐acting beta2‐agonists and long‐acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of single‐inhaler LABA/LAMA combinations versus placebo on clinically meaningful outcomes in patients with stable COPD.

Saved in:
Bibliographic Details
Published in:Cochrane database of systematic reviews 2018-01, Vol.2018 (1)
Main Authors: Maqsood, Usman, Evans, David JW, Ho, Terence N, Palmer, Karen, Eccles, Fiona JR, Munavvar, Mohammed, Crossingham, Iain
Format: Article
Language:English
Subjects:
Medicine General & Introductory Medical Sciences
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of single‐inhaler LABA/LAMA combinations versus placebo on clinically meaningful outcomes in patients with stable COPD.
ISSN:1469-493X
DOI:10.1002/14651858.CD012930